Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
Non infusion5.41B45.73%
Infusion4.67B39.46%
Research and development projects1.39B11.73%
Other business363.93M3.08%
Industry
Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical manufacturing10.08B85.20%
Research and development projects1.39B11.73%
Other business363.93M3.08%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic business9.94B84.02%
International business1.89B15.98%